Stem Cell Therapy for Stroke in Germany- CBC Health Clinic
CBC Health Clinic in Munich combines innovation with 20 years of Cord Blood Banking Experience to provide therapeutic solutions for ischemic stroke survivors. Ischemic stroke survivors from around the world visit CBC Health Clinic to receive their research-based treatments using cord blood components. The components are known for providing therapeutic results with immaculate qualities of nucleated cells.
Umbilical Cord Blood Treatment for Stroke Survivors
Intravenous infusion of umbilical blood cells is a therapeutic procedure used in patients recovering from stroke. In this treatment process, the umbilical cord vein is used to collect umbilical cord blood is collected from placenta. A dose of 50 million cells per kg is required to achieve an optimum therapeutic effect. Each of these infusions includes cord blood collected from four to eight donors. After each infusion, the patient is monitored for several hours for any potential adverse reactions. The entire course of infusions is scheduled over two to three days.
In majority of cases that CBC Health has performed so far, mild improvement of cognitive and motor functions has been experienced due to cord blood infusions. Just within the first few weeks after the infusion, these functional gains become noticeable and continue for three to six months. Very rare or generally mild adverse reactions to cord blood cell infusions are noticed sometimes.
CBC Health – Redefined Stem Cell Therapy for Stroke
Over the years, the clinic has redefined the regenerative health experience for the victims of strokes. The team is constantly working on innovation to ensure high standards of efficiency along with quality and cleanliness. The medical clinics and hospitals in Germany receive high ratings for quality of care and efficiency. In fact, the German Healthcare system was ranked number 11 in the world against the 30th rank of the United States healthcare system. CBC Health Clinic follows every norm to match up to the standard of German health care system and thus provide top-rated services to the patients.
Patient-Centered Stem Cell Treatment for Stroke Survivors
CBC Health Clinic Munich offers patient-centered health solutions. They ensure that their 3-day medical program makes every patient experience safe and efficient care. They also assign a medical concierge to help patients and their family members during the treatment and post-treatment phase. The medical concierge assists the patient and family members with travel, accommodations or sightseeing requests during their stay.
Cord Blood Ischemic Stroke Treatment
Once the patient is admitted to CBCHealth clinic, they remain under the care of fully qualified doctors and experienced medical staff. The overview of treatment course follows like:
Day One: Initial Screening & Testing
Day Two: Treatment & Routine Monitoring
Day Three: Treatment & Routine Monitoring
Day Four: Final Physical Exam & Release
Once the treatment is completed, the doctor will monitor patient remotely by follow-up consultations for the duration of 12 months after the treatment.
Stem Cell Therapy for Stroke Overview
Intravenous infusion of umbilical blood cells is a therapeutic procedure used in patients recovering from stroke.
Umbilical cord blood is collected from placenta via the umbilical cord vein.
To achieve an optimum therapeutic effect, a dose of 50 million cells per kg is required, and each infusion includes cord blood collected from 4 to 8 donors.
The entire course of infusions is scheduled over two to three days, and after each infusion, the patient is monitored for several hours for any potential adverse reactions.
In the majority of patients, cord blood infusions have resulted in mild improvement of cognitive and motor functions. These functional gains become noticeable within the first few weeks after the infusion and continue for the next 3 to 6 months.
Adverse reactions to cord blood cell infusions are rare and generally mild.
Effect of Stem Cell trail for Stroke Patients
Cord blood infusion is not intended to be a replacement for standard therapy in the management of stroke, it is additional therapeutic approach that may gain additional improvement of cognitive and motor functions. In patients undergoing cord blood therapy, there no need to temporarily discontinue other types of pharmaceutical or physical therapy. Intravenous cord blood cell infusions enhance the regenerative activity of brain cells in stroke patients. Clinical studies suggest that cord blood therapy is more effective when administrated soon after stroke occurs.
Patients begin to notice improvements within a few weeks after the infusion. The cord blood cells are eliminated from the patient’s body within 6 to 8 weeks; however, patients experience functional gains over the next 3 to 6 months, with sustained functional improvement. Achieved improvement is permanent, patients do not experience worsening of the achieved improvement.
Patients with severe functional impairment may experience little or no improvement, and patients with mild or minimal impairment experience moderate improvement. Clinical studies have shown that the most important factor influencing the therapeutic effect of cord blood infusion is cell dosage. In a recent clinical trial at Duke University on pediatric cerebral palsy patients (mostly induced by stroke), only patients who received more than 25 million cells per kg showed significant therapeutic effect (Kurtzberg et al; Blood 2015). In each of our cord blood infusions, the patient receives a standard of more than 50 million cells per kg.
Another study suggests that repeated cord blood infusions may lead to further functional improvements.
CBC Health Clinic is Patient-Centered
The medical program is designed around the individual patient to make the experience as safe and efficient as possible. From day one, prospective patients are assigned a medical concierge to help guide them through the process, while answering any questions along the way. During the treatment and post-treatment phase, your medical concierge will assist you and your family members with travel, accommodations or sightseeing requests during your stay.
Why Choose CBC Health for Stem Cell Therapy for Stroke in Germany?
Cord Blood Center Group, the founding company of CBC Health has recorded many firsts in regenerative health since more than two decades. In 1997, Cord Blood Center was among the first in Europe to process and prepare cord blood for regenerative transplants. Cord Blood Center was one of the first companies in Europe to collect, process and store cord blood, cord tissue and placenta tissue with over 160,000 clients. These individuals may benefit from the regenerative effect of their cord blood in the future. Eurocord-Slovakia, a Cord Blood Center company, was among the first in Europe to establish a registry and repository for storing personal cord blood and a repository for donated cord blood which can be used for regenerative treatments for the general population.
In 2018, CBC Health began the process to open a new medical facility in Munich, Germany, known as CBCHealth Med Munich, which will focus on providing cord blood treatments for patients suffering from Ischemic Stroke. If you are interested in learning more about the Munich location, please click here to visit, CBCHealth Med Munich.
Cord Blood Center is leading the way as a regenerative health company with a solid foundation of licensed laboratories and storage facilities. The company has active branches in Switzerland, Austria, Slovakia, Italy, Romania, Hungary, Czech Republic and is expanding into new markets. Eurocord-Slovakia is a member of the international bone marrow and cord blood donors database; it is connected to the EMDIS, the international exchange network; and it is an associate member of other prestigious international organizations that set quality standards for cord blood products such as The World Marrow Donor Association (WMDA).
For more details about stroke treatment with umbilical cord stem cell therapy at the clinic, click the button below: